ResMed | RMD - Equity Capital And Reserves


ResMed reported $6.49B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Ansell USD 1.97B 10.2M Dec/2025
Avita Medical AUD -16.65M 3.76M Dec/2025
Cochlear AUD 1.94B 12.2M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Fisher & Paykel Healthcare NZD 2.12B 129.2M Jun/2026
Healius AUD 1.03B 13.9M Dec/2024
Integral Diagnostics AUD 301.71M 1.33M Jun/2024
Mayne Pharma AUD 454.19M 93.58M Jun/2024
Nanosonics AUD 219.69M 9.78M Dec/2025
Polynovo AUD 83.14M 121K Dec/2025
Ramsay Health Care AUD 4.79B 916.1M Dec/2025
Regis Healthcare AUD -29.95M 13.22M Dec/2025
ResMed USD 6.49B 171.03M Mar/2026
Sigma Healthcare AUD 4.67B 3.8B Dec/2025
Sonic Healthcare AUD 8.2B 120.9M Dec/2024
Telix Pharmaceuticals AUD 408.17M 8.69M Jun/2026